Sensitive detection of DNA methylation

Annals of the New York Academy of Sciences

Volumn 983, Issue , 2003, Pages 120-130

  Cottrell, Susan E ^a   Laird, Peter W ^b  

^a EPIGENOMICS AG   (Germany)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Detection; Heavymethyl; Methylation; Methylation specific PCR (MSP); MethyLight; Sensitive

Indexed keywords

BIOLOGICAL MARKER; DNA;

CONFERENCE PAPER; DNA METHYLATION; DNA PROBE; GENE AMPLIFICATION; HUMAN; LAVAGE; PLASMA; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SERUM; SPUTUM; TUMOR DIAGNOSIS; URINE;

EID: 0037355974     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2003.tb05967.x     Document Type: Conference Paper

References (37)

1. POMRAT, K., K. AZIZ & G. WU. 2002. Screening for Colorectal Cancer In Cancer Screening: A Practical Guide for Physicians. K. Aziz & G. Wu, Eds.: 87-109. Humana Press. Totowa, NJ.
2. JAHR, S. et al. 2001. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res. 61: 1659-1665.
3. MARKL, I.D. et al. 2001. Global and gene-specific epigenetic patterns in human bladder cancer genomes are relatively stable in vivo and in vitro over time. Cancer Res. 61: 5875-5884.
4. HERMAN, J. et al. 1996. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA 93: 9821-9826.
5. FOY, C.A. & H.C. PARKES. 2001. Emerging homogeneous DNA-based technologies in the clinical laboratory. Clin. Chem. 47: 990-1000.
6. EADS, C.A. et al. 1999. CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. Cancer Res. 59: 2302-2306.
7. EADS, C.A. et al. 2000. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res. 28: E32.
8. LO, Y.M.D. et al. 1999. Quantitative analysis of aberrant p16 methylation using real-time quantitative methylation-specific polymerase chain reaction. Cancer Res. 59: 3899-3903.
9. JERONIMO, C. et al. 2001. Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma. J. Natl. Cancer Inst. 93: 1747-1752.
10. SOZZI, G. et al. 2001. Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients. Cancer Res. 61: 4675-4678.
11. LEON, S.A. et al. 1977. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res. 37: 646-650.
12. CHEN, X.Q. et al. 1996. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat. Med. 2: 1033-1035.
13. USADEL, H. et al. 2002. Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. Cancer Res. 62: 371-375.
14. ESTELLER, M. et al. 1999. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res. 59: 67-70.
15. Zou, H.Z. et al. 2002. Detection of aberrant p16 methylation in the serum of colorectal cancer patients. Clin. Cancer Res. 8: 188-191.
16. GRADY, W.M. et al. 2001. Detection of aberrandy methylated hMLH1 promoter DNA in the serum of patients with microsatellite unstable colon cancer. Cancer Res. 61: 900-902.
17. WONG, I.H. et al. 1999. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res. 59: 71-73.
18. KAWAKAMI, K. et al. 2000. Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma. J. Natl. Cancer Inst. 92: 1805-1811.
19. GOESSL, C. et al. 2001. DNA-based detection of prostate cancer in blood, urine, and ejaculates. Ann. N.Y. Acad. Sci. 945: 51-58.
20. CAIRNS, P. et al. 2001. Molecular detection of prostate cancer in urine by GSTP1 hypermethylation. Clin. Cancer Res. 7: 2727-2730.
21. CHAN, M.W. et al. 2002. Hypermethylation of multiple genes in tumor tissues and voided urine in urinary bladder cancer patients. Clin. Cancer Res. 8: 464-470.
22. BOTEZATU, I. et al. 2000. Genetic analysis of DNA excreted in urine: a new approach for detecting specific genomic DNA sequences from cells dying in an organism. Clin. Chem. 46: 1078-1084.
23. EVRON, E. et al. 2001. Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR. Lancet 357: 1335-1336.
24. PALMISANO, W.A. et al. 2000. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res. 60: 5954-5958.
25. SOMA, J.C. et al. 2002. Aberrant promoter methylation of multiple genes in bronchial brush samples from former cigarette smokers. Cancer Res. 62: 351-355.
26. ROSAS, S.L. et al. 2001. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res. 61(3): 939-942.
27. BELINSKY, S.A. et al. 2002. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res. 62: 2370-2377.
28. JEN, J. et al. 2000. An overview on the isolation and analysis of circulating tumor DNA in plasma and serum. Ann. N.Y. Acad. Sci. 906: 8-12.
29. CHIU, R.W. et al. 2001. Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma. Clin. Chem. 47: 1607-1613.
30. GIACONA, M.B. et al. 1998. Cell-free DNA in human blood plasma: length measurements in patients with pancreatic cancer and healthy controls. Pancreas 17: 89-97.
31. AKAMA, T.O. et al. 1997. Restriction landmark genomic scanning (RLGS-M)-based genome-wide scanning of mouse liver tumors for alterations in DNA methylation status. Cancer Res. 57: 3294-3299.
32. GONZALGO, M.L. et al. 1997. Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR. Cancer Res. 57: 594-599.
33. HUANG, T.H. et al. 1999. Methylation profiling of CpG islands in human breast cancer cells. Hum. Mol. Genet. 8: 459-470.
34. TOYOTA, M. et al. 1999. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res. 59: 2307-2312.
35. COSTELLO, J.F. et al. 2000. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat. Genet. 24: 132-138.
36. ESTELLER, M. et al. 2001. A gene hypermethylation profile of human cancer. Cancer Res. 61: 3225-3229.
37. ADORJAN, P. et al. 2002. Tumor class prediction and discovery by microarray-based DNA methylation analysis. Nucleic Acids Res. 30: e21.